# A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application

> **NCT03052842** · PHASE2 · COMPLETED · sponsor: **Armata Pharmaceuticals, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Dental Caries

## Interventions

- **DRUG:** C16G2 Strip
- **OTHER:** Placebo Strip

## Key facts

- **NCT ID:** NCT03052842
- **Lead sponsor:** Armata Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-09
- **Primary completion:** 2017-04-05
- **Final completion:** 2017-04-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03052842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03052842, "A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03052842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*